Dedicated to Research Since 1993
  •  

    info@genesismarketinsights.com

Global Veterinary Parasiticides Market By Product Type (Ectoparasiticides, Endoparasiticides, Endectocides), By Animal Type (Food-producing Animals, Companion Animals) - Business Overview, Analysis and Industry Forecast 2017-2023

 Healthcare and Pharmaceuticals

Report Overview

Global Veterinary Parasiticides Market was valued at USD XX Billion in the year 2017. Global Veterinary Parasiticides Market is further estimated to grow at a CAGR of XX % from 2018 to reach USD XX Billion by the year 2023.

Europe region holds the highest market share in 2017 and Asia Pacific market is considered as the fastest growing market in the forecasted period. At country level U.S., China and Japan are the major market in 2017 level and it is further anticipated to grow at a steady pace in the next 5 years. This can be mainly attributed to the growing livestock population and increasing pet adoption.

The global Veterinary Parasiticides solutions market is segmented based on by product, animal type, and region. On the basis of products, the global market is further segmented into endoparasiticides, ectoparasiticides, and endectocides of which endoparasiticides segment holds the highest market share with high growth rate in coming years. On the basis of animal type, the global animal parasiticides market is segmented into companion animals and food-producing animals.

Drivers:

            Rapidly increasing aging population and subsequent rise in the number of chronic diseases

            Increase in awareness for care provision

Restraints:

            High Cost of Deployment

Opportunities:

            Emerging Countries

            Cloud-Based Solutions

Challenges:

            Integration of Claim Management Solutions

Sanofi (France), Bayer AG (Germany), and Zoetis, Inc. (U.S.). Other players in this market are Boehringer Ingelheim (Germany), Ceva Sante Animale (France), Eli Lilly and Company (U.S.), Merck and Co., Inc. (U.S.), Virbac (France), Vetoquinol S.A. (France), and Perrigo Company plc (Ireland) are the market players in the Global Veterinary Parasiticides Market.

Key Benefits for Stakeholders

Veterinary Parasiticides manufacturers and distributors

Government association and regulatory bodies

Market Research and Consulting Firms

Venture Capitalists and Investors

By Product Type

Ectoparasiticides

Endoparasiticides

Endectocides

By Animal Type 

Food-producing Animals

Companion Animals

By Region

North America

Europe

Asia-Pacific

RoW

Key Market Players

Bayer HealthCare Pharmaceuticals LLC

 

Boehringer Ingelheim

 

ELI Lilly and Company

 

Merck & Co., Inc.

 

Ceva Sante Animale

 

Virbac

Zoetis. Inc.

Sanofi

Perrigo Company PLC

Vetoquinol S.A.

 

(Another brief information of 10 companies will be provided in report.)

Research Methodology:

Genesis Market Insights follows in-depth Research Methodology focused on reducing deviation in the collected data. GMI offers the most precise evaluations and projection for the market numbers. GMI engages following Market Engineering techniques –

  1.      Raw Market Data is collected and compared with the Existing in-house Data on a broad front.
  2.      Both Bottom-Up and Top-Down approaches are analyzed for segmenting and estimating measurable aspects of the market.
  3.      To avoid bias, we filter the collected data collected from authenticated sources.
  4.      GMI has a well proven Statistical Modeling System for estimates and forecasts.
  5.      Further, the report findings are validated with the Industry Expert Panel on face to face or telephonic interviews.
  6.      Panelists are approached from Leading Enterprises across the value chain including manufacturers, suppliers, technology providers, domain experts and buyers so as to validate a thorough and balanced market overview.

Detailed customization is also available for you. Further, if the report listed above does not meet with your key requirements. Our customized research report will analytically cover the required market information you need which will help you to plan your business decisions.

Table Of Content

1. Introduction

1.1 Market Vision

       1.1.1 Market Definition

       1.1.2 Market Scope

1.2 Limitations

1.3 Stakeholders

2. Research Methodology

2.1. Research Process

       2.1.1. Secondary Research

             2.1.1.1. Key Data from Secondary Research

       2.1.2. Primary Research

             2.1.2.1. Key Data from Primary Research

             2.1.2.2. Breakdowns of Primary Interviews

2.2. Market Size Estimation

       2.2.1. Bottom-Up Approach

       2.2.2. Top-Down Approach

       2.2.3. Annual Revenue Process

2.3. Data Triangulation 

2.4. Research Assumptions 

       2.4.1. Assumption

3. Executive Summary

4. Market Overview

4.1. Introduction

4.2. Drivers

4.3. Restraints

4.4. Opportunities

4.5. Challenges

4.6. Regulations

4.7. Supply Chain/Value Chain Analysis

4.8. Patent & Standards

5. Industry Trends

5.1. Introduction

5.2. Porter’s Five Forces Analysis

       5.2.1. Threat of New Entrants

       5.2.2. Threat of Substitutes

       5.2.3. Bargaining Power of Buyers

       5.2.4. Bargaining Power of Suppliers

       5.2.5. Intensity of Competitive Rivalry

6. Global Veterinary Parasiticides Market, By Product Type

6.1 Ectoparasiticides

6.2 Endoparasiticides

6.3 Endectocides

7. Global Veterinary Parasiticides Market, By Animal Type  

7.1 Food-producing Animals

7.2 Companion Animals

8. Geographical Analysis

8.1. Introduction

8.2. North America

       8.2.1. U.S.

       8.2.2. Canada

       8.2.3. Mexico

8.3. Europe

       8.3.1. U.K.

       8.3.2. Germany

       8.3.3. Italy

       8.3.4. France

       8.3.5. RoE

8.4. Asia Pacific

       8.4.1. South Korea

       8.4.2. China

       8.4.3. Japan

       8.4.4. South Korea

       8.4.5. RoAPAC

8.5. RoW

       8.5.1. Latin America

       8.5.2. Middle East and Africa

9. Company Profiles

(Business Overview, Financial Overview, Product write Up, Recent Developments)

9.1 Bayer HealthCare Pharmaceuticals LLC

9.2 Boehringer Ingelheim

9.3 ELI Lilly and Company

9.4 Merck & Co., Inc.

9.5 Ceva Sante Animale

9.6 Virbac

9.7 Zoetis. Inc.

9.8 Sanofi

9.9 Perrigo Company PLC

9.10 Vetoquinol S.A.

 

(Another brief information of 10 companies will be provided in report.)

 

10. Competitive Analysis

10.1. Introduction

10.2. Market Positioning of Key Players

10.3 Competitive Strategies Adopted by Leading Players

        10.3.1. Investments & Expansions

        10.3.2. New Product Launches

        10.3.3. Mergers & Acquisitions

        10.3.4. Agreements, Joint Ventures, and Partnerships

11. Appendix

11.1. Questionnaire

11.2. Available Customizations 

11.3. Upcoming Events (Trade Fair, Exhibitions, Conferences)

 

* The list of tables and figures will be provided in the sample report.

Summary

No Content Available.

PURCHASE OPTIONS

ASK FOR SPECIAL PRICING

Related Reports